1910 A MULTIPLEX MODEL OF COMBINING POSITIVE AND NEGATIVE MARKERS IN URINE FOR EARLY DIAGNOSIS OF PROSTATE CANCER
Da-Long Cao,Xu-Dong Yao,Ding-Wei Ye,Yao Zhu,Hai-Liang Zhang
DOI: https://doi.org/10.1016/j.juro.2011.02.2048
2011-01-01
Abstract:You have accessJournal of UrologyProstate Cancer: Detection and Screening1 Apr 20111910 A MULTIPLEX MODEL OF COMBINING POSITIVE AND NEGATIVE MARKERS IN URINE FOR EARLY DIAGNOSIS OF PROSTATE CANCER Da-Long Cao, Xu-Dong Yao, Ding-Wei Ye, Yao Zhu, and Hai-Liang Zhang Da-Long CaoDa-Long Cao Shanghai, China, People's Republic of More articles by this author , Xu-Dong YaoXu-Dong Yao Shanghai, China, People's Republic of More articles by this author , Ding-Wei YeDing-Wei Ye Shanghai, China, People's Republic of More articles by this author , Yao ZhuYao Zhu Shanghai, China, People's Republic of More articles by this author , and Hai-Liang ZhangHai-Liang Zhang Shanghai, China, People's Republic of More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.2048AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Newly emerged multiplex urine-based test outperforms single biomarker (e.g. prostate-specific antigen, PSA) in prostate cancer (PCa) diagnostics, whereas its combined mode has to be fully optimized. Our endeavor is directed to determine whether a strategy of integrating positive and negative makers in urine could optimize a multiplex model for diagnosing PCa. METHODS Using quantitative PCR and western blot, expression patterns of prostate cancer antigen 3 (PCA3, positive marker) and Annexin A3 (negative marker) were measured in urine samples from 86 untreated patients with PCa and 45 patients with no evidence of malignancy, confirmed by 10 core prostate biopsies. Multivariate logistic regression analysis using Akaike information criterion-based backward selection was used to generate a final panel. The diagnostic performance of each single marker and the final panel were assessed using receiver-operating characteristic (ROC) analysis and special bootstrap software. RESULTS Univariate and multivariate logistic regression analysis revealed that PCA3, Annexin A3 and a panel including these biomarkers were significant predictors of PCa in both groups of all patients and patients with PSA 4–10 ng/ml (all p<0.05). By ROC analysis, the areas under the curves (AUCs) of the panel in these two cohorts were 0.829 and 0.782, respectively, which outperform that of any single biomarker (serum PSA: 0.566 and 0.511; PCA3: 0.739 and 0.733; Annexin A3: 0.728 and 0.716; respectively). CONCLUSIONS These results showed that integrating positive and negative makers has effect on optimizing a panel for predicting PCa. Further validation experiments and optimization for the strategy of constructing multiplex urine-based test are awaited before it reaches the clinic. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e763-e764 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Da-Long Cao Shanghai, China, People's Republic of More articles by this author Xu-Dong Yao Shanghai, China, People's Republic of More articles by this author Ding-Wei Ye Shanghai, China, People's Republic of More articles by this author Yao Zhu Shanghai, China, People's Republic of More articles by this author Hai-Liang Zhang Shanghai, China, People's Republic of More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...